United Imaging has expanded its molecular imaging PET/CT uMI Panvivo line and updated its PET/MR line.
The Panvivo portfolio now includes uMI Panvivo Mobile, a compact PET/CT. The scanner can be paired with an automated clinical workflow supported by an 80-slice CT configuration (pending U.S. Food and Drug Administration 510(k) clearance), or a 160-slice CT configuration for cardiac and general imaging, according to the company. The line features uExcel DPR and uExcel Focus and offers multiple PET axial fields of views.
On display at SNMMI 2026, the company also showcased its uMI Panorama GS, a long-axial-field-of-view PET/CT featuring a 148 cm axial field of view for whole-body PET imaging.
In addition, the company highlighted its uPMR Zenith, a PET/MR system designed for oncology, neurology, drug development, and theranostics applications. The uPMR Zenith is currently pending FDA 510(k) clearance and is not available for clinical use in the U.S., the company noted.









![(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within seven days. (D) Multimodal imaging evaluation of Patient Three, including x-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/mei.XUQJWkpAJI.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)



![RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/screenshot-2026-05-27-205827.278Ys6PYU3.png?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)


